Singular Genomics Systems, Inc. (OMIC)
NASDAQ: OMIC · IEX Real-Time Price · USD
0.381
+0.010 (2.72%)
May 17, 2024, 4:30 PM EDT - Market closed
Singular Genomics Systems Revenue
Singular Genomics Systems had revenue of $2.49M in the twelve months ending March 31, 2024, with 52.95% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $442.00K, a -48.78% decrease year-over-year. In the year 2023, Singular Genomics Systems had annual revenue of $2.91M with 280.52% growth.
Revenue (ttm)
$2.49M
Revenue Growth
+52.95%
P/S Ratio
11.60
Revenue / Employee
$9,765
Employees
255
Market Cap
28.89M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.91M | 2.15M | 280.52% |
Dec 31, 2022 | 765.00K | - | - |
Dec 31, 2021 | 0 | - | - |
Dec 31, 2020 | 0 | - | - |
Dec 31, 2019 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Spectral AI | 19.30M |
DURECT | 8.32M |
Oncternal Therapeutics | 1.15M |
Femasys | 1.05M |
Biora Therapeutics | 544.00K |
OMIC News
- 4 days ago - Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 2 months ago - Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 - GlobeNewsWire
- 3 months ago - Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform - GlobeNewsWire
- 3 months ago - Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis - GlobeNewsWire
- 4 months ago - Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue - GlobeNewsWire
- 6 months ago - Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results - GlobeNewsWire
- 7 months ago - Singular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023 - GlobeNewsWire